The levels of integrin α(v)β5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells

Gene Therapy

Volumn 5, Issue 3, 1998, Pages 361-368

  Takayama, K ^a   Ueno, H ^a   Pei, X H ^a   Nakanishi, Y ^a   Yatsunami, J ^a   Hara, N ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Adenovirus mediated gene transfer; Integrin; Lung cancer cells; p53; Susceptibility

Indexed keywords

BETA GALACTOSIDASE; INTEGRIN; PROTEIN P53;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS CELL INTERACTION;

ADENOVIRIDAE; BACTERIA (MICROORGANISMS); DNA VIRUSES;

EID: 0031908989     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300608     Document Type: Article

References (30)

1. Levine AJ. p53, The cellular gatekeeper for growth and division. Cell 1997; 88: 323-331.
2. Chert P, Chen Y, Bookstein R, Lee W. Genetic mechanisms of tumor suppression by the human p53 gene. Science 1990; 250: 1576-1579.
3. Cajot J-F et al. Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein. Cancer Res 1992; 52: 6956-6960.
4. Shaw P et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Nail Acad Sci USA 1992; 89: 4495-4499.
5. Takahashi T et al. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res 1992; 52: 2340-2343.
6. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-967.
7. Fujiwara T et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wildtype p53 gene. Cancer Res 1994; 54: 2287-2291.
8. Nigro JM et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342: 705-708.
9. Takahashi T et al. p53: A frequent target for genetic abnormalities in lung cancer. Science 1989; 246: 491-494.
10. Liu T-J et al. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 1994; 54: 3662-3667.
11. Zhang WW et al. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1994; 1: 5-13.
12. Mujoo K, Maneval DC, Anderson SC, Gutterman JU. Adenovirus-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma Oncogene 1996; 12: 1617-1623.
13. Thomas JW, Mathias P, Cheresh DA, Nemerow GR. Integrins αβ3 and αβ5 promote adenovirus internalization but not virus attachment Cell 1993; 73: 309-319.
14. Ascadi G et al. Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Therapy 1994; 1: 338-340.
15. Mitsudomi T et al. p53 Gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 1992; 7: 171-180.
16. Mette SA, Pilewski J, Buck CA, Albelda SM Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells in vitro and in vivo. Am J Resp Cell Mol Biol 1993; 8: 562-572.
17. Hirasawa M, Shijubo N, Uede T, Abe S. Integrin expression and ability to adhere to extracellular matrix proteins and endothelial cells in human lung cancer lines. Br J Cancer 1994; 70: 466-473.
18. Falcioni R et al. Expression of βl, β3, β4 and β5 integrins by human lung carcinoma cells of different histotypes. Exp Cell Res 1994; 210: 113-122.
19. Bergelson JM et al. Isolation of a common receptor for Coxsakie B viruses and adenoviruses 2 and 5. Science 1997; 275:1320-1323.
20. Katayose D et al. Cytotoxic effects of adenovirus-mediated wildtype p53 protein expression in normal and tumor mammary epithelial cells, clin Cancer Res 1995; 1: 889-897.
21. Li J-J et al. Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. Cardiovasc Res 1995; 30: 97-105.
22. Li J-J et al. Adenovirus-mediated arterial gene transfer does not require prior injury for submaximal gene expression. Gene Therapy 1995; 2: 351-354.
23. Ueno H et al. Quantitative analysis of repeated adenovirusmediated gene transfer into injured canine femoral arteries. Arteriosol Thromb Vase Biol 1995; 15: 2246-2253.
24. Miyake S et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996; 93: 1320-1324.
25. Yamamoto H, Ueno H, Ooshima A, Takeshita A Adenovirusmediated transfer of a truncated transforming growth factor (TGF)-β type II receptor completely and specifically abolishes diverse signaling by TGF-β in vascular wall cells in primary culture. J Biol Chem 1996; 271: 16253-16259.
26. Eustice DC et al. A sensitive method for the detection of βgalactosidase in transfected mammalian cells. Biotechniques 1991, 11: 739-742.
27. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay J Immunol Meth 1983; 65: 55-63.
29. Nakanishi Y et al. Insulin-like growth factor-1 can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 1988; 82: 354-359.
30. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996; 381: 713-716.